As of 2026-03-24, the Relative Valuation of Crescita Therapeutics Inc (CTX.TO) is 0.37 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.74 CAD, the upside of Crescita Therapeutics Inc based on Relative Valuation is -49.8%.
The range of the Relative Valuation is 0.30 - 0.44 CAD.
| Range | Selected | |
| Trailing P/E multiples | 7.6x - 11.3x | 9.4x |
| Forward P/E multiples | 7.6x - 11.3x | 9.4x |
| Fair Price | 0.30 - 0.44 | 0.37 |
| Upside | -59.7% - -39.9% | -49.8% |
| Date | P/E |
| 2026-03-23 | 18.74 |
| 2026-03-20 | 18.74 |
| 2026-03-19 | 18.74 |
| 2026-03-18 | 18.74 |
| 2026-03-17 | 18.99 |
| 2026-03-16 | 18.48 |
| 2026-03-13 | 11.77 |
| 2026-03-12 | 11.77 |
| 2026-03-11 | 12.03 |
| 2026-03-10 | 12.03 |
| 2026-03-06 | 11.39 |
| 2026-03-05 | 11.65 |
| 2026-03-03 | 11.65 |
| 2026-03-02 | 12.15 |
| 2026-02-27 | 11.90 |
| 2026-02-24 | 11.90 |
| 2026-02-23 | 12.15 |
| 2026-02-19 | 12.41 |
| 2026-02-17 | 12.41 |
| 2026-02-12 | 11.90 |
| 2026-02-11 | 12.28 |
| 2026-02-10 | 12.03 |
| 2026-02-06 | 12.66 |
| 2026-02-05 | 13.17 |
| 2026-02-04 | 12.66 |
| 2026-02-03 | 12.41 |
| 2026-01-30 | 12.66 |
| 2026-01-29 | 12.66 |
| 2026-01-28 | 12.53 |
| 2026-01-27 | 13.17 |
| 2026-01-23 | 12.91 |
| 2026-01-21 | 12.66 |
| 2026-01-20 | 12.66 |
| 2026-01-19 | 12.28 |
| 2026-01-16 | 12.28 |
| 2026-01-15 | 12.15 |
| 2026-01-14 | 12.66 |
| 2026-01-13 | 12.53 |
| 2026-01-12 | 12.41 |
| 2026-01-09 | 11.77 |
| 2026-01-08 | 11.90 |
| 2026-01-07 | 12.66 |
| 2026-01-06 | 12.41 |
| 2025-12-29 | 12.15 |